Francis Patrick Ostronic - 08 Nov 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role: Director
Signature: /s/ Francis Patrick Ostronic
Issuer symbol: CYTH
Transactions as of: 08 Nov 2022
Transactions value $: $0
Form type: 4
Filing time: 09 Nov 2022, 15:03:09 UTC
Previous filing: 22 Sep 2022
Next filing: 09 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTH	Common Stock	Award	$0	+11,803	+7.83%	$0	162,490	08 Nov 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2022. The number of shares received in lieu of cash was calculated based on the closing price of $1.17 per share of common stock on November 7, 2022.

Content

Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2022. The number of shares received in lieu of cash was calculated based on the closing price of $1.17 per share of common stock on November 7, 2022.